{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001345099","name":"MESOBLAST LTD","summary":"Mesoblast Limited is an Australian biotechnology company specializing in allogeneic cellular medicines for inflammatory diseases. Its first FDA-approved product, Ryoncil (remestemcel-L), treats steroid-refractory acute graft-versus-host disease (SR-aGVHD) in pediatric patients aged 2 months and older in the United States, launched in March 2025. Additional pipeline candidates include MPC-150-IM for chronic heart failure, MPC-06-ID for chronic low back pain, and MPC-300-IV for inflammatory conditions.","people":[],"products":[{"name":"Ryoncil (remestemcel-L)","type":"service","description":"FDA-approved allogeneic cellular medicine for steroid-refractory acute graft-versus-host disease in pediatric patients aged 2 months and older; launched in the US in March 2025."},{"name":"MPC-150-IM","type":"service","description":"Pipeline cellular medicine product candidate for Class II-IV Chronic Heart Failure."},{"name":"MPC-06-ID","type":"service","description":"Pipeline cellular medicine product candidate for Chronic Low Back Pain."},{"name":"MPC-300-IV","type":"service","description":"Pipeline cellular medicine product candidate for inflammatory conditions."}],"partnerships":[{"partner_name":"Oaktree Capital Management, L.P.","partnership_type":"strategic","description":"Five-year senior secured debt facility entered November 2021; outstanding balance $44.3 million as of June 30, 2025.","start_date":null},{"partner_name":"NovaQuest Capital Management, L.L.C.","partnership_type":"strategic","description":"Eight-year non-dilutive term credit facility entered June 2018, $30 million drawn, repayable from net sales of Ryoncil in pediatric SR-aGVHD.","start_date":null}],"affiliations":[],"origin":{"leaf":"011b0cdd6281fd6b2e8b8485f94fcf610a65584690e050057a07034212576046","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"21ab2776b6359bdaa58127d9a73711094bbd4653f5b4af054d31639fdc713d14","parent":"90e3aa38beaaf40389b4997b17e0829dafbfcd889d3bcf18c4cf1da767c0700f","source":"0001345099-25-000067","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":167,"hourly_limit":500,"remaining":333,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}